Identification of redox/repair protein Ref-1 as a potent activator of p53

Genes and Development

Volumn 11, Issue 5, 1997, Pages 558-570

  Jayaraman, Lata ^a   Murthy, Kanneganti G K ^a   Zhu, Cheng ^a   Curran, Tom ^b   Xanthoudakis, Steve ^c   Prives, Carol ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

independent stimulation; p53 activation; redox dependent; redox repair; Ref 1 protein

Indexed keywords

PROTEIN P53;

ARTICLE; DNA REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN ISOLATION;

EID: 0030900605     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.5.558     Document Type: Article

References (43)

1. Abate, C., L. Patel, F.J. Rauicher III, and T. Curran. 1990. Redox regulation of Fos and Jun DNA binding activity in vitro. Science 249: 1157-1161.
2. Bellomo, G., M. Vairetti, L. Stivala, F. Mirabelli, P. Richelmi, and S. Orrenius. 1992. Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Natl. Acad. Sci. 89: 4412-4416.
3. Chen, D.S., T. Herman, and B. Demple. 1991. Two distinct human DNA diesterases that hydrolyze 3′-blocking deoxyribose fragments from oxidized DNA. Nucleic Acids Res. 19: 5907-5914.
4. Delphin, C. and J. Baudier. 1994. The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of Ras-transformed embryo fibroblasts growth arrest. J. Biol. Chem. 269: 29579-29587.
5. Delphin, C., P. Cahen, J.J. Lawrence, and J. Baudier. 1994. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding, Eur. J. Biochem. 223: 683-692.
6. Demple, B., T. Herman, and D.S. Chen. 1991. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: Definition of a family of DNA repair enzymes. Proc. Nat. Acad. Sci. 88: 11450-11454.
7. Dignam, J.D., P.L. Martin, B.S. Shastry, and R.G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol 101: 582-598.
8. Drapkin, R., A. Sancar, and D. Reinberg. 1994. Where transcription meets repair. Cell 77: 9-12.
9. Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild-type p53 activates transcription in vitro. Nature 358: 83-86.
10. Friedlander, P., Y. Haupt, C. Prives, and M. Oren. 1996. A mutant p53 that discriminates between p53 responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16: 4961-4971.
11. Fiscella, M., N. Zambrano, S.J. Ullrich, T. Unger, D. Lin, B. Cho, W.E. Mercer, C.W. Anderson, and E. Appells. 1994. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 9: 3249-3257.
12. Gottlieb, M.T. and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102.
13. Graeber, T.G., C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and A.J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379: 88-91.
14. Hainault, P. and J. Milner. 1993. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53: 4469-4473.
15. Halazonetis, T.D. and A.N. Kandil. 1993. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12: 5057-5064.
16. Halazonetis, T.D., L.J. Davis, and A.N. Kandil. 1993. Wild-type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J. 12: 1021-1028.
17. Holmgren, A. 1984. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Methods Enzymol. 107: 295-351.
18. Hupp, T.R. and D.P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4: 865-875.
19. Hupp, T.R., D.W. Meek, C.A. Midgley, and D.P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71: 875-886.
20. Hupp, T.R., A. Sparks, and D.P. Lane. 1995. Small peptides activate the latent sequence specific DNA binding function of p53. Cell 83: 237-245.
21. Jayaraman, L. and C. Prives. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021-1029.
22. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes &. Dev. 10: 1054-1072.
23. Leveillard, T., L. Andera, N. Bissonnette, L. Schaeffer, L. Bracco, J.-M. Egly, and B. Wasylyk. 1996. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 15: 1615-1624.
24. Marston, N.J., T. Crook, and K.H. Vousden. 1994. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild-type transformation suppressor function. Oncogene 9: 2707-2716.
25. Meister, A. and M.E. Anderson. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
26. Okamoto, K. and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13: 4816-4822.
27. Prywes, R. and R. Roeder. 1987. Purification of the c-Fos enhancer binding protein. Mol. Cell. Biol. 7: 3483-3489.
28. Rainwater, R., D. Parks, M.E. Anderson, P. Tegtmeyer, and K. Mann. 1995. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15: 3892-3903.
29. Robson, C.N. and I.D. Hickson. 1991. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res. 19: 5519-5523.
30. Seki, S., K. Akiyama, S. Watanabe, M. Hatsushika, S. Ikeda, and K. Tsutsui. 1991. cDNA and deduced amino acid sequence of a mouse DNA repair enzyme (APEX nuclease) with significant homology to Escherichia coli exonuclease III. J. Biol. Chem. 266: 20797-20802.
31. Shaw, P., J. Freeman, R. Bovey, and R. Iggo. 1996. Regulation of specific DNA binding by p53: Evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12: 921-930.
32. Slingerland, J.M., J.R. Jenkins, and S. Benchimol. 1993. The transforming and suppressor functions of p53 alleles: Effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J. 12: 1029-1037.
33. Vogelstein, B. and K.W. Kinzler. 1992. p53 function and dysfunction. Cell 70: 523-526.
34. Walker, L.J., R.B. Craig, A.L. Harris, and I.D. Hickson. 1994. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res. 22: 4884-4889.
35. Wang, X.W., H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J.-M. Egly, Z. Wang, E.G. Friedberg, M.K. Evans, B.G. Taffe, V.A. Bohr, G. Weeda, J.H.J. Hoeijmakers, K. Forrester, and C.C. Harris. 1995. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10: 188-193.
36. Wang, Y. and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91.
37. Xanthoudakis, S. and T. Curran. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA binding activity. EMBO J. 11: 653-665.
38. Xanthoudakis, S., G. Miao, F. Wang, Y.-C.E. Pan, and T. Curran. 1992. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11: 3323-3335.
39. Xanthoudakis, S., G.G. Miao, and T. Curran. 1994. The redox and DNA-repair activities of Ref-1 are encoded by non-overlapping domains. Proc. Natl. Acad. Sci. 91: 23-27.
40. Xanthoudakis, S., R.J. Smeyne, J.D. Wallace, and T. Curran. 1996. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl Acad. Sci. 93: 8919-8923.
41. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J.L. Regier, S.J. Triezenberg, D. Reinberg, O. Flores, C.J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14: 7013-7024.
42. Yao, K.-S., S. Xanthoudakis, T. Curran, and P.J. O'Dwyer. 1994. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14: 5997-6003.
43. Zauberman, A., A. Lubp, and M. Oren. 1995. Identification of p53 target genes through immune selection of genomic DNA: The cyclin G gene contains two distinct p53 binding sites. Oncogene 10: 2361-2366.